Collaboration to achieve change


In 2012, Indiana civic and corporate leaders called for building a non-profit research institute that could attract world class research talent to Indiana to enable discovery science and innovation, working in collaboration with academic and industry researchers.

IBRI was initially funded with $50 million provided by the State, Lilly Endowment, Eli Lilly and Company, Roche Diagnostics, Dow AgroSciences, Indiana University Health and Indiana University School of Medicine. In February 2016, we received an additional $100 million in funding commitments from Lilly Endowment Inc. and Eli Lilly and Company Foundation.


Q1 Milestones:

  • $100 million Endowment and Lilly Foundation announcement
  • Start build-out for first core laboratory facility
  • Hire first researcher
  • Initiate first research project


  • Formed Scientific Advisory Board (SAB)
  • Hired David Broecker as President and CEO
  • Hired Advancement Director and Chief of Staff
  • Opened IBRI facilities at BRTC
  • Secured land and $75 million in financing for 16 Tech
  • Hired Raghu Mirmira as Interim Scientific Director


  • Completed IP and academic frameworks
  • Received IRS tax exempt status
  • Launched permanent site activities


  • IBRI legal entity formed
  • Board of directors named
  • Secured $50 million in funding commitments


  • John Lechleiter speech calling for IBRI

Subscribe to our email list

Interested in: